Blar i Bergen Open Research Archive på forfatter "Norheim, Ole Frithjof"
-
Addressing inequity to achieve the maternal and child health millennium development goals: looking beyond averages
Ruhago, George M.; Ngalesoni, Frida; Norheim, Ole Frithjof (Peer reviewed; Journal article, 2012-12-27)Background: Inequity in access to and use of child and maternal health interventions is impeding progress towards the maternal and child health Millennium Development Goals. This study explores the potential health gains ... -
Allocating external financing for health: a discrete choice experiment of stakeholder preferences
Grépin, Karen A.; Pinkstaff, Crossley B.; Hole, Arne Risa; Henderson, Klara; Norheim, Ole Frithjof; Røttingen, John-Arne; Ottersen, Trygve (Peer reviewed; Journal article, 2018-02-05)Most donors of external financing for health use allocation policies to determine which countries are eligible to receive financial support and how much support each should receive. Currently, most of these policies place ... -
Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: An assessment of the feasibility of post-2015 goals
Verguet, Stéphane; Norheim, Ole Frithjof; Olson, Zachary D.; Yamey, Gavin; Jamison, Dean T. (Peer reviewed; Journal article, 2014-12)Background Measuring a country’s health performance has focused mostly on estimating levels of mortality. An alternative is to measure rates of decline in mortality, which are more sensitive to changes in health policy ... -
Availability and access in modern obstetric care: a retrospective population-based study
Engjom, Hilde Marie; Morken, Nils-Halvdan; Norheim, Ole Frithjof; Klungsøyr, Kari (Peer reviewed; Journal article, 2014)Objective: To assess the availability of obstetric institutions, the risk of unplanned delivery outside an institution and maternal morbidity in a national setting in which the number of institutions declined from 95 to ... -
Avoiding 40% of the premature deaths in each country, 2010-30: Review of national mortality trends to help quantify the UN Sustainable Development Goal for health
Norheim, Ole Frithjof; Jha, Prabhat; Admasu, Kesetebirhan; Godal, Tore; Hum, Ryan J.; Kruk, Margaret E.; Gómez-Dantés, Octavio; Mathers, Colin D.; Pan, Hongchao; Sepúlveda, Jaime; Suraweera, Wilson; Verguet, Stéphane; Woldemariam, Addis T.; Yamey, Gavin; Jamison, Dean T.; Peto, Richard (Peer reviewed; Journal article, 2015-09-18)Background. The UN will formulate ambitious Sustainable Development Goals for 2030, including one for health. Feasible goals with some quantifiable, measurable targets can influence governments. We propose, as a quantitative ... -
Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance
Baltussen, Rob; Mikkelsen, Evelinn; Tromp, Noor; Hurtig, Anne Karin; Byskov, Jens; Olsen, Øystein Evjen; Bærøe, Kristine; Hontelez, Jan A.; Singh, Jerome; Norheim, Ole Frithjof (Peer reviewed; Journal article, 2013-10-09)South Africa, the country with the largest HIV epidemic worldwide, has been scaling up treatment since 2003 and is rapidly expanding its eligibility criteria. The HIV treatment programme has achieved significant results, ... -
Bedside Rationing Under Resource Constraints—A National Survey of Ethiopian Physicians’ Use of Criteria for Priority Setting
Defaye, Frehiwot Berhane; Danis, Marion; Wakim, Paul; Berhane, Yemane; Norheim, Ole Frithjof; Miljeteig, Ingrid (Peer reviewed; Journal article, 2019)In low-income settings resource constraints force clinicians to make harsh choices. We examine the criteria Ethiopian physicians use in their bedside rationing decisions through a national survey at 49 public hospitals in ... -
Budget impact analysis of using dihydroartemisinin–piperaquine to treat uncomplicated malaria in children in Tanzania
Mori, Amani Thomas; Norheim, Ole Frithjof; Robbestad, Bjarne (Peer reviewed; Journal article, 2016-03)Background and Objective: Dihydroartemisinin–piperaquine (DhP) is a very cost effective anti-malarial drug. The aim of this study was to predict the budget impact of using DhP as a first- or second-line drug to treat ... -
The burden of household out-of-pocket health expenditures in Ethiopia: estimates from a nationally representative survey (2015–16)
Kiros, Mizan; Dessie, Ermias; Tolla, Mieraf Taddesse; Johansson, Kjell Arne; Norheim, Ole Frithjof; Memirie, Solomon Tessema; Verguet, Stéphane; Jbaily, Abdulrahman (Journal article; Peer reviewed, 2020)In Ethiopia, little is known about the extent of out-of-pocket health expenditures and the associated financial hardships at national and regional levels. We estimated the incidence of both catastrophic and impoverishing ... -
Challenges to fair decision-making processes in the context of health care services: a qualitative assessment from Tanzania
Shayo, Elizabeth H.; Norheim, Ole Frithjof; Mboera, Leonard E. G.; Byskov, Jens; Maluka, Stephen; Kamuzora, Peter; Blystad, Astrid (Peer reviewed; Journal article, 2012-06-07)Background: Fair processes in decision making need the involvement of stakeholders who can discuss issues and reach an agreement based on reasons that are justifiable and appropriate in meeting people’s needs. In Tanzania, ... -
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Wisløff, Torbjørn; Selmer, Randi M.; Halvorsen, Sigrun; Fretheim, Atle; Norheim, Ole Frithjof; Kristiansen, Ivar Sønbø (Peer reviewed; Journal article, 2012-04-04)Background: Hypertension is one of the leading causes of cardiovascular disease (CVD). A range of antihypertensive drugs exists, and their prices vary widely mainly due to patent rights. The objective of this study was to ... -
Clinical decision making in cancer care: a review of current and future roles of patient age
Tranvåg, Eirik Joakim; Norheim, Ole Frithjof; Ottersen, Trygve (Peer reviewed; Journal article, 2018-05-09)Background: Patient age is among the most controversial patient characteristics in clinical decision making. In personalized cancer medicine it is important to understand how individual characteristics do affect practice ... -
Combining evidence and values in priority setting: testing the balance sheet method in a low-income country
Makundi, Emmanuel; Kapiriri, Lydia; Norheim, Ole Frithjof (Peer reviewed; Journal article, 2007-09-24)Background: Procedures for priority setting need to incorporate both scientific evidence and public values. The aim of this study was to test out a model for priority setting which incorporates both scientific evidence and ... -
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
Fretheim, Atle; Odgaard-Jensen, Jan; Brørs, Odd; Madsen, Steinar; Njølstad, Inger; Norheim, Ole Frithjof; Svilaas, Arne; Kristiansen, Ivar Sønbø; Thürmer, Hanne; Flottorp, Signe (Peer reviewed; Journal article, 2012-04-05)Background: We conducted a systematic review of evidence from randomized controlled trials to answer the following research question: What are the relative effects of different classes of antihypertensive drugs in reducing ... -
A cost-effectiveness analysis of maternal and neonatal health interventions in Ethiopia
Memirie, Solomon Tessema; Tolla, Mieraf Taddesse; Desalegn, Dawit; Hailemariam, Mengistu; Norheim, Ole Frithjof; Verguet, Stéphane; Johansson, Kjell Arne (Peer reviewed; Journal article, 2019-05-18)Ethiopia is one of the sub-Saharan African countries contributing to the highest number of maternal and neonatal deaths. Coverage of maternal and neonatal health (MNH) interventions has remained very low in Ethiopia. We ... -
Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania
Ngalesoni, Frida Namnyak; Ruhago, Georg Mugambage; Mayige, Mary T.; Oliveira, Tiago Cravo; Robberstad, Bjarne; Norheim, Ole Frithjof; Higashi, Hideki (Peer reviewed; Journal article, 2017-08-02)Background: Tobacco consumption contributes significantly to the global burden of disease. The prevalence of smoking is estimated to be increasing in many low-income countries, including Tanzania, especially among women ... -
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania
Mori, Amani Thomas; Ngalesoni, Frida; Norheim, Ole Frithjof; Robberstad, Bjarne (Peer reviewed; Journal article, 2014-09-15)Background: Dihydroartemisinin-piperaquine (DhP) is highly recommended for the treatment of uncomplicated malaria. This study aims to compare the costs, health benefits and cost-effectiveness of DhP and artemether-lumefantrine ... -
Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania
Ruhago, George M.; Ngalesoni, Frida Namnyak; Robberstad, Bjarne; Norheim, Ole Frithjof (Peer reviewed; Journal article, 2015-04-28)Background. Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the ... -
Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country – the case of Tanzania
Robberstad, Bjarne; Hemed, Yusuf; Norheim, Ole Frithjof (Peer reviewed; Journal article, 2007-02-22)Background: There is a high and rising prevalence of cardiovascular risk in sub-Saharan Africa, a development typical for countries in epidemiological transition. Contrary to recommendations in treatment guidelines, medical ... -
Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study
Ngalesoni, Frida; Ruhago, George M.; Mori, Amani T.; Robberstad, Bjarne; Norheim, Ole Frithjof (Peer reviewed; Journal article, 2016-05-17)Background. Cardiovascular disease (CVD) is a growing cause of mortality and morbidity in Tanzania, but contextualized evidence on cost-effective medical strategies to prevent it is scarce. We aim to perform a cost-effectiveness ...